Citation Tools

Download PDFPDF

Original research
Phase II, randomised, double-blind, multicentre study evaluating the safety and efficacy of filgotinib and lanraplenib in patients with lupus membranous nephropathy

Download to a citation manager

Cite this article as:
Baker M, Chaichian Y, Genovese M, et al
Phase II, randomised, double-blind, multicentre study evaluating the safety and efficacy of filgotinib and lanraplenib in patients with lupus membranous nephropathy